• No results found

HPTLC determination of artesunate as bulk drug and in pharmaceutical formulations

N/A
N/A
Protected

Academic year: 2020

Share "HPTLC determination of artesunate as bulk drug and in pharmaceutical formulations"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1: Typical chromatogram of artesunate

References

Related documents

This project consists of three phases: (1) developing measurable, prioritized point-of-care criteria for effective PACT coordination, to be accomplished using ProMES (detailed

Best fits of the persistence probability q(t) of negative and positive NDVI trends obtained by exponential decay laws for climate regions: (a) Mediterranean mountains; (b)

anti-DENV2: Anti-dengue virus serotype − 2; ASE: Aqueous soluble extract; CC 50 : 50% cytotoxic concentration; cDNA: Complementary DNA; DENV: Dengue virus; EE: Ethanol extract;

Although the overwhelming majority of physicians sur- veyed indicated that they referred patients for at least one CAM modality, we found that over 63% of obstetric/gyne-

One can envision a scenario in which mold-specific (MS) genes would exert an overriding effect, i.e., expression of a mold-specific gene(s) would shift growth to the mold form and

Most parents felt it was better to discuss the possibility of death early in the course of the disease. If handled openly, there were no instances of a sibling using this information

While this has been an important element of research on the functioning of the global refugee regime in recent years, our engagement with recent discussions on new forms and

Data from a Phase II clinical trial of patients with colitis suggest that vedolizumab may be effective for induction of clinical response and remission in patients